In vivo, near-direct application of insulin on the CNS, via intranasal or intracerebroventricular treatments, are highly effective in promoting various aspects of neuronal health, as demonstrated in a rat model of PD (Haas et al., 2016; Pang et al., 2016). This evidence concerns the gene INS and Parkinson disease.